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INTRODUCTION
The protozoan parasite Plasmodium falciparum, responsible for the most deadly form of malaria, causes more than 1 million deaths each year. 1 In this severe context, many drugs currently used to fight the infective disease are becoming less effective due to growing resistance displayed by the parasite in several countries, particularly in Southeast Asia. The completion of the P. falciparum genome sequence, 2 as well as those of other apicomplexan parasites, has promoted many efforts in the search for new drug targets and for novel antimalarial agents.
Prerequisites for an ideal drug target are that the selected protein be part of a unique metabolic pathway and essential for the survival or virulence of the parasite, but ideally not present in the human host. From this point of view, apicomplexan parasites may be remarkably vulnerable since they harbor a unique organelle, the apicoplast, which is a cryptic plastid originated from the secondary endosymbiosis of a red alga. 3 This organelle has been shown to be essential for parasite survival both in P. falciparum and Toxoplasma gondii. 4, 5 Thus, the metabolic pathways present or supposed to be localized in the apicoplast 6 are currently exploited as drug targets sources for the development of antimalarial agents. 7 We have recently proposed the apicoplast redox system comprising the plant-type ferredoxin-NADP + reductase (FNR) and its substrate, the iron-sulfur protein ferredoxin (Fd), as a new potential target for design of drugs against Apicomplexa. 8 We previously reported the cloning, recombinant expression and biochemical characterization of this redox system from the apicomplexan T. gondii. [9] [10] [11] [12] More recently, it was shown that the FNR/Fd pair can reconstitute in vitro the electron transfer pathway from NADPH to the enzyme (E)-4-hydroxy-3-methyl-but-2-enyl-diphosphate (HMBPP) reductase, also called LytB or IspH, that catalyzes the last step of the mevalonate-independent isoprenoid biosynthesis in the apicoplast of the parasite. 13 Several other apicoplast enzymes or pathways have been suggested to be dependent on the FNR/Fd redox system, among others the iron-sulfur cluster biogenesis in the apicoplast. 8 All apicomplexan FNRs belong to the plant-type FNR family of enzymes, for which a very detailed functional and structural characterization has been provided over the last thirty years, as summarized in recent reviews. [14] [15] [16] [17] Up to now, the three-dimensional structure of 39
wild-type and site-directed mutant FNR forms from 6 different eukaryotic and prokaryotic sources have been deposited in the Protein Data Bank, some of which are FNR complexes with either of the two substrates, Fd or NADP(H).
In our continuous effort to understand the functional and structural aspects of plant FNRs but also to lay the foundations for exploiting apicomplexan FNRs as drug targets, we report here the basic biochemical characterization and three-dimensional structure of P. falciparum FNR (PfFNR) in two different crystal forms, in the absence and presence of the nucleotide analogue adenosine 2',5'-diphosphate (2'P-AMP). We show that PfFNR undergoes a dimerization process that is dependent on the redox conditions and on the presence of NADP + or 2'P-AMP, leading to a virtually inactive homodimeric enzyme. The structural data also show that conformational disorder affects protein loops that are specific of the apicomplexan parasite reductase, while conformational transitions at the 2'P-AMP site may promote formation of the dimeric species.
Altogether, the data presented here shed first light on the functional and structural properties of a protozoan FNR, providing a rational basis for the design of inhibitors that might be developed into antimalarial drugs. PfFNR was homogeneous by SDS-PAGE analysis, and had an electrophoretic mobility consistent with the calculated theoretical mass of 37,267 Da. PfFNR was shown to be a monomer of 28 ± 1.4 kDa by gel filtration on a Superdex 75 column in FPLC. Following the crystallization results (see below) that indicated the presence of a disulfide-stabilized PfFNR dimer in both crystal forms analyzed, the six Cys residues of the enzyme were titrated with DTNB, both under native and denaturing conditions. These experiments revealed that only one Cys could be titrated in the native protein, and practically all Cys residues (5.45) were modified in the denatured enzyme. To further proof that the PfFNR intermolecular disulfide was the result of Cys oxidation occurring during crystal growth (i.e., on a long exposure to air) two protein samples were incubated at 20 °C in the presence and absence of 1 mM DTT, respectively.
RESULTS

a) Molecular and kinetic characterization of PfFNR
Aliquots were withdrawn at different times and gel-filtered on the Superdex 75 column, as described above (see Fig. 1A ). After about seven days of aerobic incubation, a peak eluting in front of that corresponding to the PfFNR monomer was observed in the DTT-free sample. The molecular mass of this species was 44 ± 2 kDa, compatible with that expected for a PfFNR 6 dimer. The dimer peak grew in intensity with time, and was also observed in the aged sample containing 1 mM DTT. After addition of fresh DTT to both aged samples, gel-filtration showed only one protein peak corresponding to the monomeric species (data not shown).
Taken together, these data indicate that formation of a disulfide-stabilized PfFNR dimer is related to spontaneous air oxidation occurring during the relatively long time needed for the growth of PfFNR crystals. The above experiments were repeated including 1 mM 2P'-AMP in the aerobic incubation mixtures. As shown in Fig. 1B , just after 1 h of incubation under these conditions, the dimer was detectable, its amount increasing rapidly to 37% after 1 day, and to 73% after 4 days. Activity measurements after 4 days of incubation indicated that the mixture containing more than 70% of dimer was much less active (ca. 20%) than a control sample incubated for the same time. To evaluate whether formation of the dimer has any significance in vivo, NADP + was used instead of 2P'-AMP in the incubation mixture. Indeed, as shown in Figure 1C , NADP + as well is able to promote dimer formation with concomitant decrease of activity. Furthermore, dimer formation was studied with enzyme and coenzyme at more physiological concentrations by measuring residual activity. 4 μM PfFNR incubated with 200 μM NADP + yielded nearly the same amount of dimer, i.e., 10% at 1 h and 50% at 24 h versus 12% and 49%, respectively (at 300 μM PfFNR, 1 mM NADP + , Fig. 1C ). In all the above experiments, addition of 1 mM DTT completely dissociated the dimer and fully restored PfFNR enzymatic activity.
The NADPH-K 3 Fe(CN) 6 diaphorase reaction is typically used to kinetically characterize FNR enzymes, because of the simplicity of the assay and due to the fact that the reaction rate was shown to be limited by FAD reduction in the case of FNR from spinach leaves (SoFNR). reported above, while the apparent K m for NADPH was found substantially lower (Table 2 ).
NADH was also tested as a possible electron donor in the ferricyanide reduction, but it turned out to be a poor substrate. The ratio of the specificity constants (k cat /K m NADPH divided by k cat /K m NADH ) yielded a value of 70 indicating a much lower capacity of PfFNR to discriminate between the two pyridine nucleotides relative to the plant enzymes (specificity constant ratios ≥ 30,000).
The kinetic parameters were also determined for the PfFNR homodimeric species. The
PfFNR dimer produced after 36 h of aerobic incubation in the presence of 1 mM NADP + was isolated by gel-filtration as described above. The dimer exhibited the same spectral ratio A 280 /A 454 as the monomeric species. The k cat value turned out to be only 5% of that of monomeric PfFNR, while the K m for NADPH was of the same order (ca. 23 μM; see Table 2 ).
An alternative electron acceptor for FNRs is INT. As shown in 6 was found to inhibit PfFNR, its interaction with the enzyme was also studied by difference spectroscopy. Addition of the dye to the oxidized enzyme also elicited spectral perturbations of PfFNR, resulting in a difference spectrum similar to that of the 2'P-AMP complex but with distinct features (Fig. 2A) (Fig. 3A, B) . Accordingly, the FAD domain hosts a β-barrel built by two perpendicular three-stranded antiparallel beta sheets (β1β2β5 and β3β4β6) and a single α-helix (αA), nestled between β5 and β6. The C-terminal domain hosts a five-stranded parallel β-sheet (β9β8β7β10β11), surrounded by seven α-helices (αB-αH). In both crystal forms PfFNR displays five disordered surface regions: the N-terminal residues 1-4, the long loop between β3 and β4 (residues 63-97), the β5-αA loop (residues 126-133), the αB-β9 . Electrostatic compensation between residues and the inhibitor and direct hydrogen bonds between residues of the two facing protomers can be distinguished in this subset of the association interface.
g) The 2'P-AMP binding site − The 2'P-AMP molecule is located in a cleft at the C-terminal end of the core β sheet, in the NADP + binding domain, as expected. The inhibitor interacts mostly with two regions: β9-αF (hydrogen bonds to Ser247 Oγ, Tyr258 OH, Gln260 Oε1 atoms), and β10-αH (hydrogen bonds to His286 Nε2, Ser288 Oγ atoms) of the C-terminal domain, and with Lys119 Nζ of the N-terminal domain. The negative charge of the 5' phosphate is balanced by Lys119, by a putative sodium ion, and by His286, whereas the negative charge of 2' phosphate can be compensated only by Lys287 and/or Lys292, both contributed from the opposing subunit in the dimeric assembly (Fig. 4) . Moreover, the inhibitor's 2' phosphate is hydrogen bonded to the conserved residues Ser247 and Tyr258, and to Ser288 (the latter from the facing PfFNR subunit). Such series of interactions suggests that the achievement of inter-molecular electrostatic balance at the 2' phosphate might be one of the driving forces guiding PfFNR dimerization induced by 2'P-AMP or by NADP + .
The 2'P-AMP adenine moiety is stabilized by three hydrogen bonds: two connecting to the 2'-AMP adenine ring of the facing subunit (atoms N6 and N7, in a reversed Hogsteen A-A base pairing), and the third to Ser288 Oγ. The adenine is sandwiched between Tyr258 and His286, and parallel to both side chain rings, in a position matching that of 2'P-AMP in its complex with SoFNR, 22 where the 2' phosphate charge, however, is compensated intra-molecularly by the highly conserved residues Arg235 (Tyr248 in PfFNR) and Lys244 (Ser256 in PfFNR). Indeed, despite the sequence differences and the conformational transitions occurring at residues 248-257 and 289-298 of PfFNR upon binding of 2'P-AMP (described in Section h) ), the inhibitor binding mode appears essentially the same in the two enzymes, with 3 Å deviations in the position of the 5' phosphate end. Finally, it should be noted that the locations of the adenine stacking residues Tyr258 and His286 (a PfFNR specific residue) are dictated in PfFNR/2'P-AMP by their interactions with the inhibitor 2' and 5' phosphate groups, described above.
The observed PfFNR/2'P-AMP crystal structure allows to draw some hypotheses on SoFNR) is missing in PfFNR (where these residues are Tyr248 and Ser256). Such deficiency of electrostatic compensation, as described above for 2'P-AMP, could promote dimerization of PfFNR/NADP + via the interaction of the 2' phosphate with residue Lys287 from the facing subunit (Fig. 4) .
h) Conformational transitions related to 2'P-AMP binding − The most striking differences evident from the structural comparison of PfFNR/2'P-AMP and PfFNR are located in the NADP + binding domain; they involve the β9-αF loop (residues 248-257) and the αH helix (residues 289-298). In fact, in the absence of the inhibitor a hydrogen bonded salt bridge formed by His286 and the 2'P-AMP 5' phosphate is severed, and the nearby αH helix is shifted towards the FAD binding pocket by about 2 Å. Concomitantly, the β9-αF loop is shortened by 7 residues relative to PfFNR/2'P-AMP, and the αF helix is elongated by two additional turns at its Nterminus (residues Ser252-Tyr258) (Fig. 3A) . Such conformational transition linked to binding of 2'P-AMP and affecting the β9-αF and αH regions (but also the αH-β11 loop, which is disordered in the PfFNR/2'P-AMP structure) has not been observed before in any FNR, and is also reflected by a hydrogen bond stabilizing the β9-αF short loop in the inhibitor-free enzyme (Fig. 3A) . If 2'P-AMP were to bind to the PfFNR observed structure, the inhibitor adenosine 2'
phosphate moiety would collide with the amino acid region comprised between Lys249 and Ser256, whereas the 5' phosphate would be in close contact with Ser252, thus explaining the large conformational readjustments affecting the β9-αF loop described above for PfFNR/2'P-AMP (Fig. 3A) . properly shaped by the enzyme interaction with the inhibitor. Such interaction requires a substantial restructuring of 12 residues in the β9 -αF region (undergoing a helix-coil transition for residues Asn251 -Phe257), and a 2 Å shift for the αH helix. It is remarkable that, despite the unique sequence displayed by PfFNR, the elongated αF helical structure seen in this region of inhibitor-free PfFNR changes into one that is topologically much closer to ZmFNR and SoFNR, showing a shorter αF helix and a longer β9 -αF solvent exposed loop.
DISCUSSION
The dimeric assembly observed in 2'P-AMP-free PfFNR might represent a resting state of PfFNR, once the Cys99 disulfide is formed. Inspection of the 3D structures indicates that the inhibitor-free PfFNR assembly cannot give rise to the quaternary structure of PfFNR/2'P-AMP for two main reasons. On one hand, the extended α-F helix alters the subunit association interface and would yield intermolecular collisions at the 2'P-AMP binding sites. On the other, the (electrostatic) intermolecular interactions established by the inhibitor and the opposing enzyme subunit are obviously missing. None of the structural data, however, helps in assessing whether the observed dimeric form has a functional role within the apicoplast, where specific (yet uncharacterized) redox properties may prove crucial in promoting/preventing formation of the dimer-stabilizing disulfide bridge.
Our results show that in dimeric PfFNR/2'P-AMP the inhibitor 2' phosphate may be counterbalanced by the positive charges of Lys287 and/or Lys292 of the facing subunit, being stabilized by intra-and intermolecular hydrogen bonds. The crystal structure of PfFNR/2'P-AMP shows that His286, that appears to be unique to the PfFNR sequence, contributes substantially to stabilization of the 2'P-AMP inhibitor, since it is stacking over the adenine aromatic ring (the other stacking partner on the opposite adenine face being Tyr258) and it is hydrogen bonded to the inhibitor 5' phosphate. At the crystallization pH of 6.0 the His286 -2' phosphate interaction is likely to display also a strong ion pair character. This residue is part of a loop (residues 284-291) proposed to be involved in NAD(P)(H) recognition and to represent one of the determinants of coenzyme specificity within the FNR superfamily. 26 Indeed, it has been shown by sitedirected mutagenesis that Leu263 of Anabaena FNR, equivalent to His286 of PfFNR, plays a significant role in NADPH binding and discrimination against NADH, 27 though it provides only a modest apolar contact to the adenine ring of the ligand. 22, 28 From the functional viewpoint the ability of PfFNR to undergo a redox-linked inactivation/reactivation process based on a disulfide/dithiol interchange at Cys99 is so far unique in the FNR family. As shown by the crystal structures and the gel filtration experiments, the observed active and inactive forms of PfFNR correspond to its monomeric and disulfidestabilized dimeric states, respectively. Thus, the results here reported allow us to rationalize on a molecular basis the very low catalytic activity of the disulfide-linked homodimeric form of the enzyme. Indeed, the 2'P-AMP-bound form of dimeric PfFNR adopts a very compact quaternary genome, none has been described so far to be targeted to the apicoplast. 30 In a recent publication,
Nickel et al. 31 Apicoplast-resident thioredoxins would also require a thioredoxin reductase, but the single essential TrxR in P. falciparum is cytosolic. Therefore, alternative redox regulators should be sought to prevent PfFNR dimerization in vivo. One attractive possibility would be the involvement of lipoic acid (LA). Lipoate and dihydrolipoate constitute a strong redox couple (E o = -290 mV), and LA is synthesized in the apicoplast. 32, 33 Here, they exist as the protein-bound form in the E2 subunit of the apicoplast-resident pyruvate dehydrogenase complex 34 , and probably to some extent also as lipoyl-containing small peptides or lipoyl-lysine, due to normal protein-turnover. Free, unbound LA is presumably not present in the apicoplast 35 however, it has 21 been shown that protein-bound LA may interact with external disulfides in its vicinity, including thioredoxins.
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CONCLUSIONS
The first crystal structures of an apicomplexan FNR reveal structural properties that are unique to plasmodial FNRs. Besides the extensive loop flexibility observed in two independent crystal structures and the new dimerization mechanism based on the oxidation of residue Cys99 in two opposing PfFNR subunits, a helix-coil transition has been shown to occur in the substrate 
MATERIALS AND METHODS
NADH, NADP + , NADPH, 2'P-AMP and K 3 Fe(CN) 6 were purchased from Sigma; all other chemicals were of the highest grade, and used without further purification. Recombinant
PfFNR was expressed and purified as described previously.
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Spectral Analyses − Absorption spectra were recorded either on an Agilent 8453 diode-array, or a Cary 100 double-beam (Varian) spectrophotometer. The PfFNR extinction coefficient (for the protein-bound flavin) was determined spectrophotometrically. 37 Steady-state kinetic parameters were determined for the NAD(P)H-K 3 Fe(CN) 6 reductase, and the NADPH-INT reductase activities, as previously described. 10,20 The concentrations of both, the electron donor and the electron acceptor, were independently varied. Initial rate data were fitted to the equation for a ping-pong Bi-Bi mechanism by non-linear regression using the GraFit 5.0 software package (Erithacus Software Ltd., United Kingdom).
Molecular characterization methods − SDS-PAGE was carried out on 12% polyacrylamide gels.
Analytical gel-filtration analyses were performed on an ÄKTA FPLC apparatus equipped with a Superdex 75 HR 10/30 column, equilibrated in 20 mM Tris-HCl, pH 7.4, containing 100 mM NaCl.
Active-Site Titrations − Titrations of PfFNR (15 µM) with either NADP + , 2'P-AMP, and K 3 Fe(CN) 6 were performed spectrophotometrically in 20 mM Tris-HCl, pH 7.6, at 16 °C using a Cary 100 (Varian) double-beam spectrophotometer. During titrations, spectra were recorded 23 initially and after additions of equal aliquots of ligand to the sample and reference cells.
Difference spectra were computed by subtracting from each spectrum that obtained in the absence of ligand, after correction for dilution. K d values were obtained by fitting data sets by nonlinear regression to the theoretical equation for a 1:1 binding. 38 Cys residues of PfFNR were titrated with DTNB (5,5'-dithiobis (2-nitrobenzoic acid)) under native conditions and after denaturation with 6 M guanidinium chloride, in 100 mM Na-phosphate, pH 7, containing 10% glycerol and 1 mM EDTA. Table 1 ). Additional crystallization experiments (using the same experimental setup) also yielded usable crystals at lower protein and inhibitor concentrations. In this case a Table 1 .
Figures Figures 3 and 4 were produced using CCP4mp. 46 
Protein Data Bank Acsession codes
Atomic coordinates and structure factors for both PfFNR and the PfFNR/2'P-AMP complex have been deposited with the Protein Data Bank, with entry codes …, ..., respectively. The sequence numbering is referred to SoFNR (above) and PfFNR (below). The highlighted residues are those interacting with the 2'P of NADP. 
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